Friday, May 24, 2019

FDA Approves Jakafi® (ruxolitinib) for the Treatment of Patients with Acute Graft-Versus-Host Disease - Associated Press https://t.co/5PJueIpVCO


from Twitter https://twitter.com/IDROOhio

May 24, 2019 at 09:51AM

No comments:

Post a Comment